|

GBP/USD eases back to 1.4000 as week draws to a close

  • GBP/USD has eased back from prior session highs at 1.40458 but looks likely to hold onto a 1.4000 handle.
  • Positive pandemic trends, be it the UK’s vaccine rollout, news about vaccine efficacy, or falling infection rates have boosted GBP.

GBP/USD has eased back from prior session highs at 1.40458 but looks likely to hold onto a 1.4000 handle into the close of Friday FX trade at 22:00GMT. That means the pair is set for on-the-day gains of about 0.3% and gains of about 1.2% on the week. That means that AUD will just about pip sterling as the best performing currency in the G10 FX this week, up closer to 1.4% on the week versus the USD, while GBP will have to share the second spot with NZD, which is up by an almost identical magnitude on the week as sterling.

Positive pandemic related trends, be it the country’s vaccine rollout, news about vaccine efficacy, or falling virus infection rates all point in the same direction – the UK is on course to be able to reopen its economy with confidence ahead of the likes of other developed market economies such as the EU.

UK Covid-19 Updates

The UK reported 12K new Covid-19 infections on Friday, 533 new deaths and, whilst the total number of people to have received at least one Covid-19 shot jumped to nearly 17M. meanwhile, the UK government’s weekly estimate of the virus R rate has been revised lower again to 0.6-0.9 from 0.7-0.9, implying a daily growth rate -6% to -3% versus last week’s -5% to -2% infection growth rate.

Elsewhere, the Telegraph disclosed some of the findings of a Public Health England study, which is set to formally be released later in the month, which has reportedly found the vaccines to reduce Covid-19 infections and transmission by two thirds and claims it is the first study in the world to use real-world data. Furthermore, evidence continues to mount that seems to vindicate the UK’s vaccination strategy (i.e. extending the time period between the first and second doses of the Pfizer vaccine to three month from the recommended one in order to get more people vaccinated with at least one dose).

Senior government sources told the Sun that outdoor mixing will be allowed in parks and possible even gardens from 2 April. UK PM Boris Johnson Roadmap to Recovery will be finalised in a meeting with the Covid Operations war committee on Saturday, to then be officially unveiled to the public next Monday. Schools are expected to be reopened for in-person learning on 8 March, followed by the re-opening of non-essential retail. The re-opening of the hospitality, fitness and leisure sectors remains up in the air.

GBP/USD

Overview
Today last price1.4006
Today Daily Change0.0031
Today Daily Change %0.22
Today daily open1.3975
 
Trends
Daily SMA201.3764
Daily SMA501.3636
Daily SMA1001.339
Daily SMA2001.3074
 
Levels
Previous Daily High1.3986
Previous Daily Low1.384
Previous Weekly High1.3866
Previous Weekly Low1.368
Previous Monthly High1.3759
Previous Monthly Low1.3451
Daily Fibonacci 38.2%1.393
Daily Fibonacci 61.8%1.3896
Daily Pivot Point S11.3881
Daily Pivot Point S21.3787
Daily Pivot Point S31.3735
Daily Pivot Point R11.4028
Daily Pivot Point R21.408
Daily Pivot Point R31.4174

Author

Joel Frank

Joel Frank

Independent Analyst

Joel Frank is an economics graduate from the University of Birmingham and has worked as a full-time financial market analyst since 2018, specialising in the coverage of how developments in the global economy impact financial asset

More from Joel Frank
Share:

Editor's Picks

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.
 

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold surrenders some gains, back below $5,000

Gold is giving away part of its earlier gains on Thursday, receding to the sub-$5,000 region per troy ounce. The precious metal is finding support from renewed geopolitical tensions in the Middle East and declining US Treasury yields across the curve in a context of further advance in the Greenback.

XRP edges lower as SG-FORGE integrates EUR stablecoin on XRP Ledger

Ripple’s (XRP) outlook remains weak, as headwinds spark declines toward the $1.40 psychological support at the time of writing on Thursday.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.